COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1566: Articles 15651-15660  | Next

SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021: Implications for vaccination policy
Abu Jabal, K., Ben Amram, H., Beiruti, K., Brimat, I., Abu Saada, A., Bathish, Y., Sussan, C., Zarka, S., Edelstein, M.
10.1101/2021.04.11.21255273 — Posted: 2021-04-16
The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada
Groves, H. E., Piche-Renaud, P.-P., Peci, A., Farrar, D., Buckrell, S., Bancej, C., Sevenhuysen, C., Campigotto, A., Gubbay, J., Morris, S.
10.1101/2021.04.15.21255591 — Posted: 2021-04-16
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Das, S., Beare, P. A., Andresson, T., Best, S. M., Compton, A. A.
10.1101/2021.04.15.440067 — Posted: 2021-04-16
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
Peter, A. S., Roth, E., Schulz, S. R., Fraedrich, K., Steinmetz, T., Damm, D., Hauke, M., Richel, E., Mueller-Schmucker, S., Habenicht, K., Eberlein, V., Issmail, L., Uhlig, N., Dolles, S., Gruner, E., Peterhoff, D., Ciesek, S., Hoffmann, M., Pohlmann, S., McKay, P. F., Shattock, R. J., Wolfel, R., Wagner, R., Eichler, J., Schuh, W., Neipel, F., Ensser, A., Mielenz, D., Tenbusch, M., Winkler, T. H., Grunwald, T., Uberla, K., Jack, H.-M.
10.1101/2021.04.16.440101 — Posted: 2021-04-16
Viral neuroinvasion and neurotropism without neuronal damage in the hACE2 mouse model of COVID-19
Seehusen, F., Clark, J. J., Sharma, P., Subramaniam, K., Wunderlin Giuliani, S., Hughes, G., Patterson, E. I., Michael, B. D., Owen, A., Hiscox, J. A., Stewart, J. P., Kipar, A.
10.1101/2021.04.16.440173 — Posted: 2021-04-16
Multiplex Fragment Analysis Identifies SARS-CoV-2 Variants
Clark, A. E., Wang, Z., Cantarel, B. L., Kanchwala, M., Xing, C., Chen, L., Irwin, P., Xu, Y., Oliver, D., Lee, F., Gagan, J. R., Park, J. Y., Filkins, L., Muthukumar, A., Sarode, R., SoRelle, J. A.
10.1101/2021.04.15.21253747 — Posted: 2021-04-16
Randomized, Comparative, Clinical Trial to Evaluate Efficacy and Safety of PNB001 in Moderate COVID-19 Patients
Lattman, E., Bhalerao, P., BL, S., Nargundkar, N., Lattmann, P., Pillai K, S., Balaram, P. N.
10.1101/2021.04.16.21255256 — Posted: 2021-04-16
Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada
Zinszer, K., McKinnon, B., Bourque, N., Zahreddine, M., Charland, K., Papenburg, J., Fortin, G., Hamelin, M.-E., Saucier, A., Apostolatos, A., Pierce, L., Savard-Lamothe, A., Carbonneau, J., Conrod, P., Haley, N., Laurin, I., Boivin, G., De Serres, G., Quach, C.
10.1101/2021.04.14.21255499 — Posted: 2021-04-16
Comorbidity Risk Factors Contributing to COVID-19 Related Deaths in Florida, March 1, 2020-January 16, 2021
Weiss, U. K., Maynard, J. D., McDaniel, K., Cohen, A., Bailey, M., Rivkees, S. A.
10.1101/2021.04.14.21255434 — Posted: 2021-04-16
The impact of COVID-19 upon the delivery of exercise services within cystic fibrosis clinics in the United Kingdom
Tomlinson, O. W., Saynor, Z. L., Stevens, D., Urquhart, D., Williams, C. A.
10.1101/2021.04.12.21255205 — Posted: 2021-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).